MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $1.7M of Moderna, Inc.
Sold$1,731,951
$115.46Price
15,000Shares
What MRNA did after the filing
- The stock from Tue, Sep 5 open, $112.72
- −23.4%
- S&P 500, same days
- −2.9%
Measured over 30 trading days, to the Oct 17 close.
Traded Wed, Aug 30. Filed Fri, Sep 1, 7:00 PM ET, after the close. Returns use the Sep 5 open and the Oct 17 close. Not investment advice.